Evidence map›Paper›PMID 36613036›Full record

Observational studyInternational journal of environmental research and public health2022

Substance Use and Psychological Distress in Mexican Adults during COVID-19 Pandemic: A Cross-Sectional Study.

Juan Carlos Ibarrola-Peña, Tania Abigail Cueto-Valadez, Jonathan Matías Chejfec-Ciociano, Luis Rodrigo Cifuentes-Andrade, Andrea Estefanía Cueto-Valadez, Guadalupe Castillo-Cardiel, Guillermo Alonso Cervantes-Cardona, Enrique Cervantes-Pérez, Gabino Cervantes-Guevara, Mario Jesús Guzmán-Ruvalcaba and 11 more

Abstract readObservational Study
In one paragraph

Observational study in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Juan Carlos Ibarrola-PeñaHospital General y Medicina Familiar de Zona No. 2, Instituto Mexicano del Seguro Social, Monterrey 64010, Nuevo León, Mexico.
Tania Abigail Cueto-ValadezUnidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.
Jonathan Matías Chejfec-CiocianoUnidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.
Luis Rodrigo Cifuentes-AndradeUnidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.
Andrea Estefanía Cueto-ValadezUnidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.
Guadalupe Castillo-CardielUnidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.
Guillermo Alonso Cervantes-CardonaDepartamento de Disciplinas Filosófico, Metodológicas e Instrumentales, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
Enrique Cervantes-PérezDepartamento de Medicina Interna, Hospital Civil de Guadalajara Fray Antonio Alcalde, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0002-6333-9082
Gabino Cervantes-GuevaraDepartamento de Bienestar y Desarrollo Sustentable, Centro Universitario del Norte, Universidad de Guadalajara, Colotlán 46200, Jalisco, Mexico.
Mario Jesús Guzmán-RuvalcabaUnidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0002-3048-8639
José Héctor Sapién-FernándezUnidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.
José Aldo Guzmán-BarbaUnidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.
Isaac Esparza-EstradaUnidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.
Paola Flores-BecerrilUnidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.
Irma Valeria Brancaccio-PérezUnidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.
Bertha Georgina Guzmán-RamírezDepartamento de Pediatría, Hospital Civil de Guadalajara Fray Antonio Alcalde, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
Andrea Socorro Álvarez-VillaseñorInstituto Mexicano del Seguro Social, La Paz 23060, Baja California, Mexico.
Francisco José Barbosa-CamachoUnidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0002-3897-2767
Emilio Alberto Reyes-ElizaldeDepartamento de Traumatología y Ortopedia, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Tlalpan, Ciudad de Mexico 14389, Mexico.
Clotilde Fuentes-OrozcoUnidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.
Alejandro González-OjedaUnidad de Investigación Biomédica 02, Hospital de Especialidades del Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0003-2935-8703

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis observational cross-sectional study examined changes in substance use during the coronavirus disease 2019 (COVID-19) pandemic in the Mexican population and evaluated whether depression or anxiety was associated with these new consumption patterns.

methodsAn online survey was distributed to the general population. Participants were questioned about their demographics, situation during the COVID-19 pandemic, and substance consumption patterns. The Patient Health Questionnaire-9 for depression and the Coronavirus Anxiety Scale were used.

resultsA total of 866 individuals completed the survey. The mean scores for the Patient Health Questionnaire-9 and Coronavirus Anxiety Scale were 8.89 ± 6.20 and 3.48 ± 3.22, respectively. The preferred substances were alcohol (19%), tobacco (16.5%), and marijuana (5.6%). Consumption of alcohol (

conclusionsSubstance use patterns were affected by the pandemic, with an increase in the number of users and consumption rate, as well as the reported psychiatric symptoms.

Indexed as

COVID-19Psychological DistressSubstance-Related DisordersAdultAnxietyCross-Sectional StudiesDepressionFemaleHumansMalePandemicsSARS-CoV-2Stress, Psychologicaladdictionanxietyassessmentdepressiondrug and alcohol usepsychometrics

Identifiers

PMID36613036
PMCPMC9819856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.